JPRN-jRCT2053210009进行中（未招募）1 期
An Exploratory Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients with Cerebral Palsy
Ookawa Sumito0 个研究点目标入组 6 人开始时间: 2021年4月21日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 1age old 至 < 2age old（—）
- 性别
- All
入选标准
- •1) Age >= 12 months and < 24 months corrected age at the time of informed consent
- •2) Diagnosed with cerebral palsy
- •3) Diagnosed with PVL
- •4) GMFCS level between II and IV
- •5) Able to obtain written infomed consent from parents (legal representative)
排除标准
- •1) Presence of progressive neurological disease
- •2) Presence of congenital anomaly
- •3) Diagnosed with Grade 3 or more severe IVH
- •4) Body weight < 5kg
- •5) Profound intellectual disorder
- •6) Complication of serious infection such as sepsis
- •7) Requirement of mechanical ventilation
- •8) Complication of serious organ failure such as kidney, liver or heart diseases or others and considered to be inappropriate
- •9) Diagnosed with or suspected of hypsarrhythmia
- •10) Positive for HBV, HCV, HIV or HTLV-1
- •11) Patients who have recived cell therapy
- •12) Patients who have undergone SDR or received botulinum toxin products within a certain period of time
研究者
相似试验
招募中
2 期
An Exploratory Study to Evaluate the Safety of the High-Intensity Focused Ultrasound(HIFU) in Patients with saggingFacial saggingJPRN-jRCTs032230634Mizuno Hiroshi10
进行中（未招募）
2 期
Physician-initiated clinical trial in patients with 5-aminolevulinic acid-induced ATR-X syndrome.infant, intellectual disability, epigenetics, guanine quadruplexD008607ATR-X syndromeJPRN-jRCT2051220062Wada Takahito5
进行中（未招募）
1 期
Study to evaluate the safety, tolerability and efficacy of AZD4831 in thetreatment of patients with pulmonary hypertensioEUCTR2020-002788-80-DEniversity of Cologne15
招募中
1 期
Exploratory Study on the Safety and Effectiveness of Yizhi Qingxin Decoction (Capsules) in the Treatment of Hypertension in the Elderly With Mild Cognitive Impairment (Deficiency of Kidney Essence Syndrome)ITMCTR2000003062Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
尚未招募
2 期
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shockCardiogenic and septic shock up to level CInflammationShock, SepticCardiovascular DiseasesVascular DiseasesSepsisHeart DiseasesShock, CardiogenicShockPathologic ProcessesMyocardial InfarctionMyocardial IschemiaSystemic Inflammatory Response SyndromeRPCEC00000426Center for Genetic Engineering and Biotechnology (CIGB)234